Interleukin-1 Receptor Antagonist [EPC]

10227 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 3014
1 DRUG INEFFECTIVE 2901
2 RHEUMATOID ARTHRITIS 1193
3 PAIN 1070
4 JOINT SWELLING 1028
5 CONDITION AGGRAVATED 917
6 DRUG INTOLERANCE 868
7 ARTHRALGIA 814
8 INJECTION SITE PAIN 692
9 NAUSEA 671
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 267 0.9175
1 HUMAN ANTI-HUMAN ANTIBODY TEST 16 0.7273
2 INFILTRATION ANAESTHESIA 21 0.7000
3 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 9 0.4737
4 BODY HEIGHT BELOW NORMAL 280 0.4682
5 ACTINOMYCOTIC SEPSIS 7 0.4667
6 ANKLE ARTHROPLASTY 55 0.3056
7 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 11 0.2500
8 INTESTINAL SEPSIS 37 0.2403
9 SHORT STATURE 14 0.2000
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]